Research
Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the stomach, where they block acid production. Researchers at the German Cancer Research Center (DKFZ) made the surprising discovery that zinc-carrying proteins, which are found in all […]
read more
Deutschlands wichtigste Wette auf die Zukunft (Handelsblatt, erschienen am 07.02.2025)
Handelsblatt | 07.02.2025 —Innovation — Deutschlands wichtigste Wette auf die Zukunft Handelsblatt Insight Biotechnologie zählt zu den vielversprechendsten Wirtschaftsfeldern. Die Bundesrepublik zeigt dabei laut einer neuen Studie überraschende Stärken. Experten sehen allerdings Probleme, die dringend gelöst werden müssen. Der deutsche Mikrobiologe Robert Koch findet 1882 den Erreger für die Krankheit Tuberkulose. 1895: Wilhelm Conrad Röntgen entdeckt in […]
read more
BioMed X Launches New Institute in Barbados
BioMed X Institute, in collaboration with the Government of Barbados and the European Commission, is launching BioMed X Barbados, a new research initiative focused on better treatment of cardiometabolic diseases in individuals of African descent. Heidelberg, Germany / Bridgetown, Barbados – February 20, 2025. BioMed X Institute is proud to announce a partnership with the […]
read more
Taking biological imaging to the next level
Extraordinary funding from the Chan Zuckerberg Initiative supports two large collaborative projects that will boost imaging technology development By Stephanie Alexander, EMBL Imaging Centre Research & Service Coordinator Developing advanced imaging technologies is critical to advancing life sciences research. It is especially important to explore the detailed structure and function of tissues, cells, and macromolecules […]
read more
A special puppeteer holds the strings to liver cells’ identity
Scientists at EMBL and DKFZ have discovered how cells in the liver maintain their identity and avoid becoming tumour cells Summary A collaboration between EMBL Heidelberg and the German Cancer Research Centre (DKFZ) led to the identification of a special protein in liver cells, which helps maintain the cells’ identity throughout their lifetime and prevents […]
read more
Funding for globally accessible rapid identification of tumor cells
A combination of new laboratory technology and artificial intelligence is set to make the rapid and precise differentiation of subgroups of brain tumours widely available. An international research group led by Professor Dr. Dr. Felix Sahm from the Department of Neuropathology at Heidelberg University Hospital and the Heidelberg Faculty of Medicine at Heidelberg University is […]
read more
Multiple myeloma: When cancer cells break out of the bone marrow, dangerous diversity develops
A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center has discovered new details about the spread of the incurable bone marrow cancer “multiple myeloma” in the body: When the cancer cells break out of the bone and […]
read more
How the HIV-1 Capsid Cracks the Barrier of the Human Nucleus
New evidence points towards a forceful entry of HIV-1 capsid into the nucleus of human cells Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as they enter the cell nucleus through specialized channels called nuclear pores. In an exciting interdisciplinary study, they propose a new mechanism […]
read more
Bacteria, brains, and sugar: scientists uncover new connections
Using a new method to study how carbohydrates modify proteins, scientists have discovered that gut bacteria can alter molecular signatures in the brain Summary Our guts are home to trillions of bacteria, and research over the last few decades has established how essential they are to our physiology – in health and disease. A new study […]
read more
